Axios Homepage
1 ✊🏿 thing
Latest stories
Sen. Kelly Loeffler to return to campaign trail after 2nd negative test
5 hours ago - Politics & PolicyDurbin seeks to replace Feinstein as top Democrat on Senate Judiciary Committee
7 hours ago - Politics & PolicyTracking Biden's first calls to world leaders
8 hours ago - WorldCoronavirus dashboard
10 hours ago - Politics & PolicyGM abandons Trump lawsuit against California over emissions standards
10 hours ago - Energy & EnvironmentWatch: The future of broadband connectivity
11 hours ago - Axios EventsMichigan board certifies Biden's win
11 hours ago - Politics & PolicyToday’s top stories
Moderna exec says children could be vaccinated by mid-2021
Tal Zaks, chief medical officer of Moderna, tells "Axios on HBO" that a COVID-19 vaccine could be available for children by the middle of next year.
Be smart: There will be a coronavirus vaccine for adults long before there is one for kids.
1 ✊🏿 thing
Sen. Kelly Loeffler to return to campaign trail after 2nd negative test
Sen. Kelly Loeffler addresses supporters during a rally on Thursday. Photo: Jessica McGowan/Getty Images
Sen. Kelly Loeffler's (R-Ga.) campaign announced Monday that she "looks forward to getting back out on the campaign trail" after testing negative for COVID-19 for a second time, following earlier conflicting results.
Why it matters: Loeffler has been campaigning at events ahead of a Jan. 5 runoff in elections that'll decide which party holds the Senate majority. Vice President Mike Pence was with her on Friday.
Key government agency says Biden transition can formally begin
General Services Administrator Emily Murphy. Photo: Alex Edelman/CNP/Getty Images
General Services Administrator Emily Murphy said in a letter to President-elect Joe Biden on Monday that she has determined the transition from the Trump administration can formally begin.
Why it matters: Murphy, a Trump appointee, had come under fire for delaying the so-called "ascertainment" and withholding the funds and information needed for the transition to begin while Trump's legal challenges played out.
Coronavirus dashboard
Illustration: Aïda Amer/Axios
- Vaccines: Key information about the effective COVID-19 vaccines — Oxford and AstraZeneca's vaccine won't just go to rich countries.
- Health: U.S. coronavirus hospitalizations keep breaking records — Why we're numb to 250,000 deaths.
- World: England to impose stricter regional system — U.S. hotspots far outpacing Europe's — Portugal to ban domestic travel for national holidays.
- Economy: The biggest pandemic labor market drags.
- Sports: Coronavirus precautions leave college basketball schedule in flux.
Michigan board certifies Biden's win
Poll workers count absentee ballots in Detroit, Michigan on Nov. 4. Photo: Salwan Georges/The Washington Post via Getty Images
The Michigan Board of State Canvassers certified the state's election results on Monday, making President-elect Joe Biden's win there official and granting him the state's 16 electoral votes.
Why it matters: Republican Party leaders had unsuccessfully appealed to delay the official certification, amid the Trump campaign's failed legal challenges in key swing states.
Biden to nominate Janet Yellen as Treasury secretary
Photo: Photo by Alex Wong/Getty Images
President-elect Joe Biden is preparing to nominate former Fed Chair Janet Yellen as his Treasury Secretary, four people familiar with the matter tell Axios.
Why it matters: Yellen, 74, will bring instant economic celebrity to Biden’s team and, if confirmed, she will not only be the first female Treasury Secretary but also the first person to have held all three economic power positions in the federal government: the chair of Council of Economic Advisers, the chair of Federal Reserve and the Treasury Secretary.
Bob Nelsen on AstraZeneca and his plan to revolutionize biotech
AstraZeneca and the University of Oxford on Monday reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and may be distributed earlier in developing countries.
Axios Re:Cap digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who on Monday launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.
Unpacking Joe Biden's decision to tap John Kerry as his climate envoy
Photo: Pablo Blazquez Dominguez/Getty Images
President-elect Joe Biden is naming former Secretary of State John Kerry as a special presidential envoy for climate change.
Why it matters: The transition team's announcement sought to show that it will be an influential role, noting that Kerry — a former Massachusetts senator and the Democrats' 2004 presidential nominee — will be on the National Security Council.
Oxford and AstraZeneca's vaccine won't just go to rich countries
Waiting, in New Delhi. Photo: Jewel Samad/AFP via Getty Images
While the 95% efficacy rates for the Moderna and Pfizer/BioNTech vaccines are great news for the U.S. and Europe, Monday's announcement from Oxford and AstraZeneca may be far more significant for the rest of the world.
Why it matters: Oxford and AstraZeneca plan to distribute their vaccine at cost (around $3-4 per dose), and have already committed to providing over 1 billion doses to the developing world. The price tags are higher for the Pfizer ($20) and Moderna ($32-37) vaccines.
Biden transition names first Cabinet nominees
Tony Blinken at the U.S. embassy in Baghdad in 2016. Photo: Pool / The Embassy of the United States of America in Baghdad/Anadolu Agency/Getty Images
President-elect Joe Biden on Monday unveiled his nominations for top national security positions in his administration, tapping former Secretary of State John Kerry as his climate czar and former deputy national security adviser Avril Haines as director of national intelligence.
Why it matters: Haines, if confirmed, would make history as the first woman to oversee the U.S. intelligence community. Biden also plans to nominate Alejandro Mayorkas to become the first Latino secretary of the Department of Homeland Security.
New deals in the COVID economy
Illustration: Sarah Grillo/Axios
COVID-19 is the macro horror of our lifetimes, and has destroyed or severely damaged countless businesses. But, like with most horribles, it also has created some opportunities.
Driving the news: Merck this morning announced an agreement to buy OncoImmune, a Maryland-based biotech that showed promising late-stage clinical results for a therapy that treats severe and critical coronavirus cases.
Biden's openings for tech progress
Photo illustration: Eniola Odetunde/Axios. Photo: Win McNamee/Getty Images
Item No. 1 on President-elect Joe Biden's day-one tech agenda, controlling the flood of misinformation online, offers no fast fixes — but other tech issues facing the new administration hold out opportunities for quick action and concrete progress.
What to watch: Closing the digital divide will be a high priority, as the pandemic has exposed how many Americans still lack reliable in-home internet connections and the devices needed to work and learn remotely.
Saudi Arabia denies Netanyahu met secretly with crown prince
Secretary of State Mike Pompeo, Israeli Prime Minister Benjamin Netanyahu, and Bahrain's Foreign Minister Abdullatif at a press conference on Nov. 18. Photo: Menahem Kahana/POOL/AFP via Getty Images
Israeli Prime Minister Benjamin Netanyahu traveled in secret Sunday to the city of Neom on Saudi Arabia's Red Sea coast for a meeting with Crown Prince Mohammed Bin Salman and Secretary of State Mike Pompeo, Israeli sources told me.
The latest: Saudi Foreign Minister Faisal bin Farhan on Monday denied the meeting took place — a signal that the Saudis may be unhappy with the leak or are at least trying to publicly distance themselves from the meeting. Netanyahu, on the other hand, has not denied the story.
Major regulator makes 11th-hour move to sink banks' oil limits
Illustration: Aïda Amer/Axios
A major regulator is racing to thwart big banks' refusal to lend and service certain industries and projects — including Arctic oil drilling and new coal mining.
Why it matters: America's biggest banks are increasingly scaling back ties with fossil fuel, prison and gun-manufacturing businesses amid public pressure and changing investment preferences.
Biden's dull-by-design plan
Photo: Joe Raedle/Getty Images
The most remarkable part of President-elect Biden’s campaign and early picks for positions of true power is the unremarkable — and predictable — nature of his big moves.
Why it matters: Biden is obsessed with bringing stability and conventional sanity back to governance. "He is approaching this — in part — like an experienced mechanic intent on repairing something that's been badly broken," said one source familiar with the president-elect's thinking.
Scoop: Blackstone CEO Stephen Schwarzman says Trump lost
Trump with Schwarzman in 2017. Photo: Chip Somodevilla/Getty Images
It's over. That's what Blackstone chairman, CEO and co-founder Steve Schwarzman — one of President Trump's most loyal allies — and other top Republicans are signaling to the defeated president, 16 days after Joe Biden clinched the win.
Why it matters: It’s all theatrics now. Even if Trump doesn't move on fast, you can. It is safe to ignore the fearful Republicans who insist the process is legit and plausible, because they tell us privately it is not.
U.S. coronavirus hotspots far outpacing Europe's
America's coronavirus outbreak has surpassed Europe's.
Why it matters: It wasn't long ago that public health experts were pointing to Europe as a warning sign for the U.S. But the U.S. now has a higher per capita caseload than the EU ever has during its recent surge.
Oxford University says its coronavirus vaccine is up to 90% effective
A scientist working during at the Oxford Vaccine Group's laboratory facility at the Churchill Hospital in Oxford, England, in June. Photo: Steve Parsons/Pool/AFP via Getty Images
The University of Oxford announced Monday that a COVID-19 vaccine it's developed with AstraZeneca is 70.4% effective in preventing people from developing symptoms, per interim data from Phase 3 trials.
Why it matters: The Oxford-AstraZeneca vaccine is shown to work in different age groups and can be stored at fridge temperature. It is much cheaper than other vaccines in development and is part of the global COVAX initiative, designed to ensure doses go where they're most needed.
Subsidizing and innovating away climate change
Illustration: Aïda Amer/Axios
Washington lawmakers may throw billions of taxpayer dollars at clean energy next year, prompting a rush of ideas about how to do it and how effective it can be at tackling climate change.
Driving the news: With the federal government’s political power likely divided, the biggest policies are likely to come through an economic recovery package in the form of subsidies and other spending.
Biden to name Antony Blinken as secretary of state
Anthony Blinken, then deputy secretary of state speaks at a 2016 summit 2016 in New York City. Photo: Bryan Bedder/Getty Images for Concordia Summit
President-elect Joe Biden will name as secretary of state his longtime adviser Antony Blinken, who has held diplomatic and national security jobs since the Clinton administration, a Biden adviser confirmed to Axios on Sunday.
Our thought bubble: By nominating Blinken, who has worked closely with Biden over the past two decades, Biden may return more authority to and work to rebuild the ranks and morale inside the diplomatic corps after President Trump moved to diminish its reach and centralize decision making inside the White House.